{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:54:29Z","timestamp":1790243669795,"version":"4.1.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Grant Commission, New Delhi","award":["F. NO. 41-1378\/2012"],"award-info":[{"award-number":["F. NO. 41-1378\/2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.intimp.2016.09.019","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T18:17:57Z","timestamp":1475173077000},"page":"362-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Jatinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanpreet","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-185X.2009.00105.x","article-title":"The mast cell: an evolutionary perspective","volume":"85","author":"Crivellato","year":"2010","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2014.07.124","article-title":"Ancient origin of mast cells","volume":"451","author":"Wong","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.coi.2010.08.015","article-title":"Mast cell mediators in tolerance","volume":"22","author":"de Vries","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"7106","key":"10.1016\/j.intimp.2016.09.019_bb0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.09.019_bb0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev.immunol.26.021607.090320","article-title":"The master switch: the role of mast cells in autoimmunity and tolerance","volume":"26","author":"Sayed","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.1101703","article-title":"Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides","volume":"188","author":"Wang","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2011.10.007","article-title":"Plasticity in mast cell responses during bacterial infections","volume":"15","author":"Chan","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1615\/CritRevImmunol.v31.i6.30","article-title":"Regulation of mast cell responses in health and disease","volume":"31","author":"Gilfillan","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0050","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","article-title":"Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis","volume":"13","author":"Coussens","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2016.09.019_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pathol.1.110304.100224","article-title":"Tumor stroma and regulation of cancer development","volume":"1","author":"Tlsty","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20091725","article-title":"Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice","volume":"207","author":"Biggs","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2015.09.002","article-title":"Mast cells and IgE in defense against venoms: possible \u201cgood side\u201d of allergy?","volume":"65","author":"Galli","year":"2016","journal-title":"Allergol. Int."},{"key":"10.1016\/j.intimp.2016.09.019_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yexcr.2016.03.013","article-title":"The development of human mast cells. An historical reappraisal","volume":"342","author":"Ribatti","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jlb.61.3.233","article-title":"Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase","volume":"61","author":"Welle","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0080","first-page":"136","article-title":"Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3 T3 fibroblasts","volume":"77","author":"Irani","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2016.09.019_bb0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mai.2000.108107","article-title":"Regulation of chymase production in human mast cell progenitors","volume":"106","author":"Ahn","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0090","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD341+\/Fc\u03b5RI2\u2212 cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0095","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.151.8.4221","article-title":"Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD341+, Ly\u2212, CD14\u2212, CD17\u2212, colony-forming cell","volume":"151","author":"Agis","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2013.02.011","article-title":"Human mast cells arise from a common circulating progenitor","volume":"132","author":"Maaninka","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2015-06-650648","article-title":"Lin\u2212 CD34hi CD117int\/hi Fc\u03b5RI+ cells in human blood constitute a rare population of mast cell progenitors","volume":"127","author":"Dahlin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.09.019_bb0110","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.09.019_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2015.07.016","article-title":"Murine and human mast cell progenitors","volume":"778","author":"Schmetzer","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.019_bb0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0125","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1073\/pnas.0504197102","article-title":"Identification of mast cell progenitors in adult mice","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.09.019_bb0130","doi-asserted-by":"crossref","first-page":"18105","DOI":"10.1073\/pnas.0509148102","article-title":"Developmental checkpoints of the basophil\/mast cell lineages in adult murine hematopoiesis","volume":"102","author":"Arinobu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.09.019_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.immuni.2013.06.012","article-title":"Antagonistic regulation by the transcription factors C\/EBPalpha and MITF specifies basophil and mast cell fates","volume":"39","author":"Qi","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0140","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0145","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0150","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and Fc\u03f5RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.09.019_bb0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4049\/jimmunol.150.2.556","article-title":"Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 and IL-4","volume":"150","author":"Coleman","year":"1993","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4049\/jimmunol.149.2.599","article-title":"The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils","volume":"149","author":"Columbo","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2003-08-2769","article-title":"NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following kit activation and Fc\u03f5RI aggregation","volume":"104","author":"Tkaczyk","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0170","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and Fc\u03f5RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"issue":"7011","key":"10.1016\/j.intimp.2016.09.019_bb0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature02991","article-title":"Essential role for the p110\u03b4 phosphoinositide 3-kinase in the allergic response","volume":"431","author":"Ali","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.09.019_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0065-2776(05)88004-6","article-title":"Role of human mast cells and basophils in bronchial asthma","volume":"88","author":"Marone","year":"2005","journal-title":"Adv. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1471-4906(02)02215-9","article-title":"Trends in histamine research: new functions during immune responses and hematopoiesis","volume":"23","author":"Schneider","year":"2002","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1471-4159.2012.07858.x","article-title":"Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway","volume":"123","author":"Chu","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2016.09.019_bb0195","first-page":"263","article-title":"CXCR2: from bench to bedside","volume":"3","author":"Zarbock","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molmed.2006.02.005","article-title":"Emerging roles of DP and CRTH2 in allergic inflammation","volume":"12","author":"Kostenis","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","article-title":"The tyrosine kinase network regulating mast cell activation","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol. Rev."},{"issue":"7542","key":"10.1016\/j.intimp.2016.09.019_bb0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2004.04.005","article-title":"The K+ channel IK Ca 1 potentiates Ca 2+ influx and degranulation in human lung mast cells","volume":"114","author":"Duffy","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0225","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.4049\/jimmunol.167.8.4261","article-title":"Resting and activation-dependent ion channels in human mast cells","volume":"167","author":"Duffy","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0005-2736(03)00210-4","article-title":"Extracellular ATP as a signaling molecule for epithelial cells","volume":"1615","author":"Schwiebert","year":"2003","journal-title":"BBA-BIOMEMBRANES"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddstr.2008.05.007","article-title":"Targeting innate immunity for CV benefit","volume":"5","author":"Moore","year":"2008","journal-title":"Drug Discov. Today Ther. Strateg."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0240","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1164\/rccm.201303-0442OC","article-title":"Toll-like receptor 7 rapidly relaxes human airways","volume":"188","author":"Drake","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1579-2129(10)70034-3","article-title":"Role of toll-like receptors in respiratory diseases","volume":"46","author":"Crespo-Lessmann","year":"2010","journal-title":"Arch. Bronconeumol. (English Edition)"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/mi.2009.124","article-title":"The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis","volume":"3","author":"Lavelle","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0255","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cellsig.2013.03.010","article-title":"IgE production in CD40\/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma","volume":"25","author":"Hong","year":"2013","journal-title":"Cell. Signal."},{"issue":"24","key":"10.1016\/j.intimp.2016.09.019_bb0260","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.09.019_bb0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2012.00117","article-title":"The Fyn-STAT5 pathway: a new frontier in IgE-and IgG-mediated mast cell signaling","volume":"3","author":"Pullen","year":"2012","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fimmu.2012.00143","article-title":"The SNARE machinery in mast cell secretion","volume":"3","author":"Lorentz","year":"2012","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0280","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood-2007-07-103309","article-title":"VAMP-8 segregates mast cell\u2013preformed mediator exocytosis from cytokine trafficking pathways","volume":"111","author":"Tiwari","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0285","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/eji.200737634","article-title":"Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells","volume":"38","author":"Sander","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301277","article-title":"Munc18-2 and syntaxin 3 control distinct essential steps in mast cell degranulation","volume":"192","author":"Brochetta","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0295","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1242\/jcs.02338","article-title":"Complexin II facilitates exocytotic release in mast cells by enhancing Ca2+ sensitivity of the fusion process","volume":"118","author":"Tadokoro","year":"2005","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0300","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0854.2007.00571.x","article-title":"Rab27b regulates mast cell granule dynamics and secretion","volume":"8","author":"Mizuno","year":"2007","journal-title":"Traffic"},{"issue":"29","key":"10.1016\/j.intimp.2016.09.019_bb0305","doi-asserted-by":"crossref","first-page":"19445","DOI":"10.1074\/jbc.M109.002550","article-title":"Synaptotagmin-2 controls regulated exocytosis but not other secretory responses of mast cells","volume":"284","author":"Melicoff","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0310","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.4049\/jimmunol.1202323","article-title":"The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis","volume":"191","author":"Kraft","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0315","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20131926","article-title":"DOCK5 functions as a key signaling adaptor that links Fc\u03b5RI signals to microtubule dynamics during mast cell degranulation","volume":"211","author":"Ogawa","year":"2014","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0320","first-page":"L925","article-title":"Role of MARCKS in regulated secretion from mast cells and airway goblet cells","volume":"306","author":"Haddock","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1091\/mbc.E10-06-0553","article-title":"Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane","volume":"22","author":"Bond","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0330","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200501111","article-title":"Fc\u03b5RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane","volume":"170","author":"Nishida","year":"2005","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0335","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bpj.2008.11.015","article-title":"Impact of actin rearrangement and degranulation on the membrane structure of primary mast cells: a combined atomic force and laser scanning confocal microscopy investigation","volume":"96","author":"Deng","year":"2009","journal-title":"Biophys. J."},{"issue":"9","key":"10.1016\/j.intimp.2016.09.019_bb0340","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.20101757","article-title":"Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b","volume":"208","author":"F\u00f6ger","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2016.09.019_bb0345","series-title":"Ultrastructure of Mast Cells and Basophils","first-page":"135","article-title":"Piecemeal Degranulation of Basophils and Mast Cells Is Effected by Vesicular Transport of Stored Secretory Granule Contents","volume":"Vol. 85","author":"Dvorak","year":"2005"},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/1523-1747.ep12543620","article-title":"Enzymes of the mast cell granule","volume":"74","author":"Schwartz","year":"1980","journal-title":"J. Invest. Dermatol."},{"issue":"7203","key":"10.1016\/j.intimp.2016.09.019_bb0355","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0360","first-page":"807","article-title":"Next generation antihistamines: therapeutic rationale, accomplishments and advances","volume":"11","author":"Casale","year":"2002"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0365","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jep.2008.07.034","article-title":"Traditional Chinese medicine for atopic eczema: pentaherbs formula suppresses inflammatory mediators release from mast cells","volume":"120","author":"Chan","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0370","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri3151","article-title":"Accessory molecules for toll-like receptors and their function","volume":"12","author":"Lee","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0375","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0625.2009.00878.x","article-title":"Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands","volume":"18","author":"Mrabet-Dahbi","year":"2009","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0380","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1189\/jlb.70.6.977","article-title":"Toll-like receptor 4-mediated activation of murine mast cells","volume":"70","author":"McCurdy","year":"2001","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0385","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.4049\/jimmunol.169.7.3801","article-title":"Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways","volume":"169","author":"Masuda","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0390","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.173.1.531","article-title":"TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells","volume":"173","author":"Matsushima","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0395","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaci.2006.06.008","article-title":"Fungal zymosan induces leukotriene production by human mast cells through a dectin-1\u2013dependent mechanism","volume":"118","author":"Olynych","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0400","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","article-title":"Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3","volume":"114","author":"Kulka","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0405","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaci.2007.03.027","article-title":"Lipoteichoic acid downregulates Fc\u03b5RI expression on human mast cells through toll-like receptor 2","volume":"120","author":"Yoshioka","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2183\/pjab.85.143","article-title":"Pathogen recognition by innate immunity and its signaling","volume":"85","author":"Akira","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0420","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of toll-like receptor 4 to the induction of interferon-\u03b2","volume":"9","author":"Kagan","year":"2008","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0430","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/cea.12509","article-title":"Differential TLR-induced cytokine production by human mast cells is amplified by Fc\u025bRI triggering","volume":"45","author":"Suurmond","year":"2015","journal-title":"Clin. Exp. Allergy"},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0435","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1136\/annrheumdis-2014-205562","article-title":"Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies","volume":"74","author":"Suurmond","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0440","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000080231","article-title":"The role of the Fc\u03b5RI \u03b2-chain in allergic diseases","volume":"135","author":"Kraft","year":"2004","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0445","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2072","article-title":"New developments in Fcε RI regulation, function and inhibition","volume":"7","author":"Kraft","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2011.00095","article-title":"Transmembrane adaptor proteins in the high-affinity IgE receptor signaling","volume":"2","author":"Draber","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0455","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0065-2776(08)00403-3","article-title":"New insights on mast cell activation via the high affinity receptor for IgE","volume":"98","author":"Rivera","year":"2008","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7174","article-title":"Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence","volume":"6","author":"Joulia","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0465","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2011","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0470","first-page":"98","article-title":"Diagnosis and management of mastocytosis: an emerging challenge in applied hematology","volume":"2015","author":"Valent","year":"2015","journal-title":"ASH Education Program Book"},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0475","first-page":"587","article-title":"Mast cell activation syndrome","volume":"4","author":"Ratner","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0480","series-title":"Mastocytosis. In Anaphylaxis","first-page":"110","volume":"Vol. 95","author":"Brockow","year":"2010"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000336374","article-title":"Evaluation of mast cell activation syndromes: impact of pathology and immunohistology","volume":"159","author":"Horny","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.019_bb0490","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrcardio.2015.117","article-title":"Mast cells in human and experimental cardiometabolic diseases","volume":"12","author":"Shi","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0495","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5114\/ceji.2015.54603","article-title":"Atherosclerosis: a chronic inflammatory disease mediated by mast cells","volume":"40","author":"Conti","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"issue":"6917","key":"10.1016\/j.intimp.2016.09.019_bb0500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature01324","article-title":"Mast cells in autoimmune disease","volume":"420","author":"Benoist","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.09.019_bb0505","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.msard.2015.11.005","article-title":"Important role of mast cells in multiple sclerosis","volume":"5","author":"Conti","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0510","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/ajrccm.149.5.8173772","article-title":"Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis","volume":"149","author":"Pesci","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0515","doi-asserted-by":"crossref","first-page":"396","DOI":"10.21037\/tau.2016.03.12","article-title":"Mast cell activation syndrome in pain syndromes bladder pain syndrome\/interstitial cystitis and vulvodynia","volume":"5","author":"Regauer","year":"2016","journal-title":"Transl. Androl. Urol."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0520","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jid.2016.03.019","article-title":"Mast cells regulate epidermal barrier function and the development of allergic skin inflammation","volume":"136","author":"Sehra","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0525","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5056\/jnm15137","article-title":"Mast cell and irritable bowel syndrome: from the bench to the bedside","volume":"22","author":"Zhang","year":"2016","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0972-2327.182302","article-title":"Understanding migraine: potential role of neurogenic inflammation","volume":"19","author":"Malhotra","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0535","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yexmp.2014.02.006","article-title":"Do mast cells play a pathogenetic role in neurofibromatosis type 1 and ulcerative colitis?","volume":"96","author":"Baratelli","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0540","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","article-title":"New aspects of liver abnormalities as part of the systemic mast cell activation syndrome","volume":"29","author":"Alfter","year":"2009","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0545","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Cutting edge: mast cells express IL-17A in rheumatoid arthritis synovium","volume":"184","author":"Hueber","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0550","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/1346-8138.13234","article-title":"Mast cell chymase in experimentally induced psoriasis","volume":"43","author":"Suttle","year":"2016","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0555","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13075-016-1036-8","article-title":"Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile","volume":"18","author":"van der Velden","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0560","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0565","first-page":"315","article-title":"Role of mast cells in tumor growth","volume":"37","author":"Conti","year":"2007","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0570","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1183\/13993003.00065-2016","article-title":"Mast cells in asthma: biomarker and therapeutic target","volume":"47","author":"Reber","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.intimp.2016.09.019_bb0575","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1681\/ASN.2008010015","article-title":"Role of mast cells in progressive renal diseases","volume":"19","author":"Holdsworth","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0580","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0976-9668.149075","article-title":"Mast cells and oral pathologies: a review","volume":"6","author":"Kamal","year":"2015","journal-title":"J. Nat. Sci. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0590","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjp.0706246","article-title":"Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells","volume":"145","author":"Kempuraj","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0595","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jaci.2014.10.032","article-title":"The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells","volume":"135","author":"Weng","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0600","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2016.09.019_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108595","article-title":"Expression of DP2 (CRTh2), a prostaglandin D 2 receptor, in human mast cells","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2016.09.019_bb0610","series-title":"CRTh2: Can Resident Time Help?, Proceedings of RSC-SCI Symposium on GPPCR2 in Medicinal Chemistry, Spain, 15\u201317 September","author":"Roberts","year":"2014"},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0620","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/ml1002234","article-title":"Discovery of AMG 853, a CRTH2 and DP dual antagonist","volume":"2","author":"Liu","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2016.09.019_bb0625","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1021\/ml200223s","article-title":"Discovery of a novel series of CRTH2 (DP2) receptor antagonists devoid of carboxylic acids","volume":"2","author":"Crosignani","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0630","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm2013997","article-title":"Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis","volume":"55","author":"Pettipher","year":"2012","journal-title":"J. Med. Chem."},{"issue":"S1","key":"10.1016\/j.intimp.2016.09.019_bb0635","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1038\/sj.bjp.0707488","article-title":"The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses","volume":"153","author":"Pettipher","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0640","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2222.2011.03813.x","article-title":"A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma","volume":"42","author":"Barnes","year":"2012","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0645","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/jm401509e","article-title":"Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases","volume":"57","author":"Kaila","year":"2014","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2016.09.019_bb0650","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1021\/jm400122f","volume":"56","author":"Fretz","year":"2013","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.019_bb0655","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1021\/jm300007n","article-title":"Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases","volume":"55","author":"Kaila","year":"2012","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.intimp.2016.09.019_bb0660","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1021\/jm050519b","article-title":"Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2","volume":"48","author":"Armer","year":"2005","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.019_bb0665","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1021\/cr900166w","article-title":"Targeting the histamine H4 receptor","volume":"111","author":"Marson","year":"2011","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0670","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.102.046581","article-title":"Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells","volume":"305","author":"Hofstra","year":"2003","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0675","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0705729","article-title":"Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation","volume":"142","author":"Ling","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0680","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.intimp.2009.02.011","article-title":"Effect of histamine H 4 receptor antagonist on allergic rhinitis in mice","volume":"9","author":"Takahashi","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0685","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-11-86","article-title":"Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines","volume":"11","author":"Cowden","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2016.09.019_bb0690","series-title":"(Pierre Fabre Medicament). WO\/2009\/071625, June 11","author":"Clerc","year":"2009"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0695","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1476-5381.2009.00236.x","article-title":"In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties","volume":"157","author":"Strakhova","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0700","unstructured":"http:\/\/www.ziarcopharma.com\/news\/3\/61\/Ziarco-Raises-33-1-Million-in-Series-B-Financing.html"},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0705","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.drudis.2014.05.007","article-title":"Histamine H4 receptor antagonists for the treatment of inflammatory disorders","volume":"19","author":"Liu","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0710","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/jm200568c","article-title":"Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4)","volume":"55","author":"Choi","year":"2012","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0715","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/13543784.2012.656197","article-title":"Development of novel CXCR4-based therapeutics","volume":"21","author":"Peled","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0720","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62562-X","article-title":"AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. The American journal of pathology","volume":"160","author":"Lukacs","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0725","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2353\/ajpath.2006.051234","article-title":"AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation","volume":"169","author":"Hu","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0730","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pharmthera.2010.04.010","article-title":"Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists","volume":"127","author":"Dufton","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0735","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mi.2013.37","article-title":"Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor","volume":"7","author":"Pundir","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0740","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2011.11.009","article-title":"Endocannabinoids limit excessive mast cell maturation and activation in human skin","volume":"129","author":"Sugawara","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0745","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/138945012800675786","article-title":"The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke","volume":"13","author":"Pini","year":"2012","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0750","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2013.01.002","article-title":"Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ","volume":"132","author":"Sugawara","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0755","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.170.10.4953","article-title":"Differential roles of CB1 and CB2 cannabinoid receptors in mast cells","volume":"170","author":"Samson","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0760","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0192623310362706","article-title":"The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin","volume":"38","author":"Kaplan","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"23","key":"10.1016\/j.intimp.2016.09.019_bb0765","doi-asserted-by":"crossref","first-page":"16887","DOI":"10.1016\/S0021-9258(19)85277-8","article-title":"The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells","volume":"268","author":"Ramkumar","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0770","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2007.08.007","article-title":"G protein-coupled receptors and the modification of Fc\u025bRI-mediated mast cell activation","volume":"113","author":"Kuehn","year":"2007","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0775","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/eji.200637024","article-title":"Adenosine closes the K+ channel KCa3. 1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor","volume":"37","author":"Duffy","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0780","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20061372","article-title":"Enhanced mast cell activation in mice deficient in the A2b adenosine receptor","volume":"204","author":"Hua","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0785","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jid.2011.334","article-title":"Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells","volume":"132","author":"Asadi","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0790","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1476-5381.2011.01631.x","article-title":"Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction","volume":"166","author":"Grammatopoulos","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0795","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects 1","volume":"139","author":"Theoharides","year":"1998","journal-title":"Endocrinol"},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_bb0800","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.4049\/jimmunol.1500253","article-title":"Identification of a new exo-endocytic mechanism triggered by corticotropin-releasing hormone in mast cells","volume":"195","author":"Balseiro-Gomez","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0805","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0091-6749(97)70280-X","article-title":"Anti-inflammatory effect of \u03b22-agonists: inhibition of TNF-\u03b1 release from human mast cells","volume":"100","author":"Bissonnette","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0810","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1440-1681.2006.04435.x","article-title":"\u03b2-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells","volume":"33","author":"Wang","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0815","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.alit.2015.05.009","article-title":"Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation","volume":"64","author":"Noguchi","year":"2015","journal-title":"Allergol. Int."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0820","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/jm801528x","article-title":"Antagonists of the P2X7 receptor. From lead identification to drug development","volume":"52","author":"Guile","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2016.09.019_bb0825","series-title":"WO 2005014555","author":"Shum","year":"2005"},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0830","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1158\/0008-5472.CAN-14-1259","article-title":"Accelerated tumor progression in mice lacking the ATP receptor P2X7","volume":"75","author":"Adinolfi","year":"2015","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2016.09.019_bb0835","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"D1520C00001 study team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate o rsulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0840","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0845","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11302-008-9110-6","article-title":"Selective P2X7 receptor antagonists for chronic inflammation and pain","volume":"5","author":"Carroll","year":"2009","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb0850","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0855","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bmcl.2004.10.052","article-title":"Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X 7 receptor antagonists","volume":"15","author":"Merriman","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0860","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","article-title":"Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373","volume":"149","author":"Stokes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0865","series-title":"WO 2001046200","author":"Meghani","year":"2001"},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0870","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bmcl.2003.10.063","article-title":"Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder","volume":"14","author":"Perez-Medrano","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0875","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0701081","article-title":"The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes","volume":"120","author":"Gargett","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0880","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/jm2012326","article-title":"Structure\u2013activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X7 receptor antagonists","volume":"55","author":"Lee","year":"2012","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0885","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jcb.20331","article-title":"Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2","volume":"94","author":"Stokes","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0890","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.20032082","article-title":"A TRPV2\u2013PKA signaling module for transduction of physical stimuli in mast cells","volume":"200","author":"Stokes","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0895","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol. Res."},{"issue":"49","key":"10.1016\/j.intimp.2016.09.019_bb0900","doi-asserted-by":"crossref","first-page":"16536","DOI":"10.1523\/JNEUROSCI.4426-10.2010","article-title":"Involvement of TRPV2 activation in intestinal movement through nitric oxide production in mice","volume":"30","author":"Mihara","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0905","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ni1550","article-title":"Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release\u2013activated calcium channels","volume":"9","author":"Vig","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0910","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cub.2007.03.065","article-title":"CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties","volume":"17","author":"Lis","year":"2007","journal-title":"Curr. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2016.09.019_bb0915","first-page":"1147","article-title":"Emerging perspectives in store-operated Ca 2+ entry: roles of Orai, stim and TRP","volume":"1763","author":"Smyth","year":"2006","journal-title":"BBA-Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2016.09.019_bb0920","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ceca.2007.02.006","article-title":"Biochemical properties and cellular localisation of STIM proteins","volume":"42","author":"Dziadek","year":"2007","journal-title":"Cell Calcium"},{"issue":"7108","key":"10.1016\/j.intimp.2016.09.019_bb0925","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature05122","article-title":"Orai1 is an essential pore subunit of the CRAC channel","volume":"443","author":"Prakriya","year":"2006","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2016.09.019_bb0930","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1096\/fj.06-6016fje","article-title":"Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and-independent pathways in mast cells","volume":"20","author":"Chang","year":"2006","journal-title":"The FASEB J."},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_bb0935","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jaci.2012.01.070","article-title":"CRACM\/Orai ion channel expression and function in human lung mast cells","volume":"129","author":"Ashmole","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.09.019_bb0940","series-title":"In Essential Allergy","first-page":"3","author":"Mygind","year":"1996"},{"issue":"7","key":"10.1016\/j.intimp.2016.09.019_bb0945","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/jm9706628","article-title":"Inhibition of Fc\u03b5RI-mediated activation of mast cells by 2,3,4-trihydropyrimidino [2, 1-a] isoquinolines","volume":"41","author":"Scholz","year":"1998","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2016.09.019_rf0945","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1398-9995.1992.tb00669.x","article-title":"Distribution of serum IgE in children and adolescents aged 7 to 16years in Copenhagen, in relation to factors of importance","volume":"47","author":"Backer","year":"1992","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_rf0950","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1164\/ajrccm\/144.4.776","article-title":"Asthma, hay fever, and phlegm production associated with distinct patterns of allergy skin test reactivity, eosinophilia, and serum IgE levels. The normative aging study","volume":"144","author":"Tollerud","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.intimp.2016.09.019_rf0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60661-6","article-title":"Regulation of immunoglobulin E biosynthesis","volume":"47","author":"Ishizaka","year":"1989","journal-title":"Adv Immunol"},{"issue":"5224","key":"10.1016\/j.intimp.2016.09.019_rf0960","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.7542803","article-title":"Molecular identification of an IgE-dependent histamine-releasing factor","volume":"269","author":"MacDonald","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2016.09.019_rf0965","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/337187a0","article-title":"Complete structure and expression in transfected cells of high affinity","volume":"337","author":"Blank","year":"1989","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_rf0970","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1398-9995.1995.tb01180.x","article-title":"The role of the basophil in allergic inflammation","volume":"50","author":"Schroeder","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2016.09.019_bb0960","first-page":"7","article-title":"Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange","author":"Pennington","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2016.09.019_bb0965","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2332\/allergolint.R-07-157","article-title":"Toll-like receptors and airway inflammation","volume":"57","author":"Gon","year":"2008","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2016.09.019_bb0970","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.coph.2012.06.002","article-title":"New developments in toll-like receptor targeted therapeutics","volume":"12","author":"Connolly","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2016.09.019_bb0975","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/jm0700619","article-title":"Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase","volume":"50","author":"Greco","year":"2007","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.intimp.2016.09.019_bb0980","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1021\/jm030050p","article-title":"Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone","volume":"46","author":"Costanzo","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2016.09.019_rf1000","first-page":"305","article-title":"Mast cell chymases and tryptases: phylogeny, family relations, and biogenesis","author":"Caughey","year":"1995","journal-title":"Mast Cell Proteases in Immunology and Biology"},{"issue":"6","key":"10.1016\/j.intimp.2016.09.019_rf1005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1165\/ajrcmb.16.6.9191463","article-title":"Of mites and men: trypsin-like proteases in the lungs","volume":"16","author":"Caughey","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2016.09.019_rf1010","series-title":"Mast Cell Tryptase: Properties and Roles in Human Allergic Responses. In Mast Cell Proteases in Immunology and Biology","first-page":"9","author":"Schwartz","year":"1995"},{"key":"10.1016\/j.intimp.2016.09.019_rf1015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0076-6879(94)44008-5","article-title":"[6] Tryptase: a mast cell serine protease","volume":"244","author":"Schwartz","year":"1994","journal-title":"Methods in Enzymology"},{"issue":"22","key":"10.1016\/j.intimp.2016.09.019_rf1020","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"6673","key":"10.1016\/j.intimp.2016.09.019_bb0995","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/32703","article-title":"Human \u03b2-tryptase is a ring-like tetramer with active sites facing a central pore","volume":"392","author":"Pereira","year":"1998","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.intimp.2016.09.019_bb1000","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1021\/bi001988c","article-title":"Heparin antagonists are potent inhibitors of mast cell tryptase","volume":"40","author":"Hallgren","year":"2001","journal-title":"Biochemist"},{"issue":"3","key":"10.1016\/j.intimp.2016.09.019_bb1005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/jm990412m","article-title":"Protease inhibitors: current status and future prospects","volume":"43","author":"Leung","year":"2000","journal-title":"J. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T17:33:19Z","timestamp":1718818399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916303939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":207,"alternative-id":["S1567576916303939"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.09.019","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}